Phospholipid Compositions for Delivery of Therapeutic Compounds

The USPTO issued Patent 12605411B2 to Aker BioMarine Human Ingredients AS covering compositions comprising phospholipids for delivery of bioactive compounds. The patent specifically names ethyl esters, fish oil concentrates, cannabinoids, CoQ10, and curcumin as target compounds whose bioavailability the compositions are designed to enhance. The filing date was June 5, 2024, with application number 18734385.

Pharmaceutical and drug delivery companies developing lipid-based formulation technologies should review this patent when designing delivery systems for poorly bioavailable compounds. Companies working with cannabinoid formulations may need to consider licensing or design-around strategies. The 16 granted claims establish intellectual property protection for this specific phospholipid delivery approach.